Almost two years after Zimbabwe's government declared a state of emergency over HIV/AIDS to allow the importation and manufacture of generic anti-AIDS drugs, accessing antiretrovirals (ARVs) remains a pipe dream for almost a million people living with HIV/AIDS in the country. With an estimated HIV prevalence rate of 27 percent, Zimbabwe is one of the countries worst hit by the epidemic.